Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

REPCF

RepliCel Life Sciences (CE) (REPCF)

RepliCel Life Sciences Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:REPCF
DateTimeSourceHeadlineSymbolCompany
01/12/202305:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
25/10/202302:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
20/10/202304:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
05/10/202305:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
08/09/202302:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
31/08/202307:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
30/08/202303:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
18/08/202301:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
31/05/202320:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
19/05/202303:59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
21/04/202303:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
17/03/202305:40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
08/02/202322:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
02/02/202322:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
27/01/202302:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
26/01/202322:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
18/01/202304:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
18/01/202303:48Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
06/01/202322:02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
09/12/202222:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
26/10/202203:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
29/09/202220:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
13/09/202220:01Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
07/09/202204:36Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
05/08/202201:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
29/07/202204:53Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
27/07/202203:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
08/07/202203:44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
01/07/202201:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
29/06/202220:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:REPCFRepliCel Life Sciences Inc (CE)
 Showing the most relevant articles for your search:USOTC:REPCF

Your Recent History

Delayed Upgrade Clock